Acquired distinctiveness in Brazil
The Brazilian Patent and Trademark Office (BPTO) has made significant strides in recognizing acquired distinctiveness in trademark law by publishing in the Official Bulletin No. 2840 of June 10, 2025, Ordinance No. 15/2025, which allows the possibility of demonstrating acquired distinctiveness through use during trademark examination. These instances are as follows: Corrobation is required to demonstrate […]
TOOLS FOR HUMANITY CASE: BRAZILIAN DPA UPHOLDS SUSPENSION OF PAYMENTS FOR IRIS COLLECTION
The company Tools for Humanity, which manufactures an advanced camera called ORB, had been collecting iris, facial, and eye data from individuals in exchange for financial compensation via a crypto asset known as World Coin (WLD). The stated purpose of iris collection, according to the company, was the development of a “unique human verification system” […]
Ozempic: The Expiration of Patent Exclusivity
Ozempic is the trademark used to designate the medication that contains the active ingredient known as semaglutide, which is used to treat diabetes. It has gained significant popularity in the Brazilian market due to its side effect of weight loss in patients who use the well-known injectable “pen.” Currently, the company Novo Nordisk A/S holds […]
